Offer - Urjas Oil for just ₹ 1 X
Mabtas is a prescription drug, available for use as Injection, Infusion. Primarily, it is used for the treatment of Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia. Secondary and off-label uses of Mabtas have also been mentioned below.
The optimal dosage of Mabtas is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Mabtas also has some side effects, the most common being Weakness. Apart from the aforementioned side effects, Mabtas can also lead to other problems, which have been listed below. These side effects of Mabtas are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Mabtas's effect during pregnancy is Moderate and Severe while nursing. Warnings related to Mabtas's effects on the liver, heart and kidney, if any, have been listed below.
Mabtas can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Mabtas in conditions like Hyperkalemia. Other conditions have been mentioned below in the Mabtas contraindications section.
Drug interactions for Mabtas have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Mabtas is not safe while driving, and is is not addictive in nature.
Mabtas is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Mabtas safe for pregnant women?
Mabtas can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Mabtas right away. Take your doctor's advice before taking it again.
Is the use of Mabtas safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Mabtas. So it is adviced to consult the doctor before using it.
What is the effect of Mabtas on the Kidneys?
There can be some harmful effects on your kidneys after taking Mabtas. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Mabtas on the Liver?
Mabtas does not damage the liver.
What is the effect of Mabtas on the Heart?
There may be an adverse effect on the heart after taking Mabtas. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Mabtas should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Mabtas unless your doctor advises you to do so -
Is this Mabtas habit forming or addictive?
No, you will not get addicted to Mabtas.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Mabtas as you may feel sleepy.
Is it safe?
Yes, but take Mabtas only as per medical advice.
Is it able to treat mental disorders?
No, the use of Mabtas in mental disorders is not effective.
Interaction between Food and Mabtas
You can take Mabtas with food.
Interaction between Alcohol and Mabtas
No research has been done on this till date. Therefore, it is not known what the effect of taking Mabtas with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872